Mathes Company Inc. Buys 1,416 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mathes Company Inc. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,586 shares of the company’s stock after purchasing an additional 1,416 shares during the period. Mathes Company Inc.’s holdings in GE HealthCare Technologies were worth $1,292,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. 9258 Wealth Management LLC increased its stake in GE HealthCare Technologies by 5.7% in the fourth quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after acquiring an additional 176 shares during the last quarter. Principal Securities Inc. bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $38,000. Level Four Advisory Services LLC lifted its position in shares of GE HealthCare Technologies by 5.7% during the 4th quarter. Level Four Advisory Services LLC now owns 3,455 shares of the company’s stock worth $267,000 after buying an additional 187 shares during the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $229,052,000. Finally, UBS Group AG grew its stake in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. UBS Group AG now owns 1,042,298 shares of the company’s stock worth $80,590,000 after buying an additional 16,372 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.27% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on GEHC shares. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday. Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective for the company. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Six equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average price target of $95.00.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $88.53 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $40.41 billion, a PE ratio of 25.89, a P/E/G ratio of 3.26 and a beta of 1.17. The firm has a fifty day simple moving average of $83.46 and a 200 day simple moving average of $83.27. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the previous year, the business earned $0.92 EPS. The firm’s revenue was up .5% compared to the same quarter last year. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $0.03 dividend. The ex-dividend date was Friday, July 19th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.